Method for treating hepatitis b carriers with minimal disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/22 (2006.01)

Patent

CA 2175046

Thymosin .alpha.-1, or biologically active fragments or analogs of thymosin .alpha.-1, are administered for treatment of minimal disease hepatitis B infection.

La thymosine .alpha.-1, ou des fragments ou des analogues biologiquement actifs de la thymosine .alpha.-1 sont administrés afin de traiter une infection par le virus de l'hépatite B avec état pathologique minime.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating hepatitis b carriers with minimal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating hepatitis b carriers with minimal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating hepatitis b carriers with minimal disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1899332

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.